Jenna Rouse - Simulations Plus Global Operations

SLP Stock

USD 11.56 -0.38 -3.18%

Executive

Jenna Rouse is Global Operations of Simulations Plus

Age	49
Address	800 Park Offices Drive, Research Triangle Park, NC, United States, 27709
Phone	661 723 7723
Web	https://www.simulations-plus.com

Simulations Plus Management Efficiency

The company has Return on Asset of 2.79 % which means that it generated a profit of $2.79 on every $100 of assets employed. This is lower than peers in the sector. In the same way, it shows a return on shareholders' equity (ROE) of -41.21 %, which indicates that equity investment in it has not been earning a positive return.

Compare Simulations Plus to Peers

Predict price of Simulations Plus

Simulations Plus has $616 K in debt with debt to equity (D/E) ratio of 0.01, which may show that Simulations Plus is not taking advantage of profits from borrowing. Simulations Plus has a current ratio of 24.0, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Note however, debt can serve as one financing mechanism for Simulations, though the impact on returns depends on execution and market conditions.

Similar Executives

Showing other executives			EXECUTIVE Age
	Peter Casasanto	Sophia Genetics SA	N/A
	Loic Vincent	Frequency Therapeutics	N/A
	Jared MBA	Kindly MD	44
	Maira Alejandra	OPTIMIZERx Corp	N/A
	Philippe Duchateau	Cellectis SA	63
	Vineet MBA	Frequency Therapeutics	43
	Madiha Derouazi	AC Immune	52
	Howard Donovan	AC Immune	50
	Stephan MSc	Cellectis SA	57
	JeanFabien Monin	AC Immune	54
	John Dalton	Kindly MD	44
	Sally Slarke	Definitive Healthcare Corp	N/A
	Ram Sharma	Definitive Healthcare Corp	N/A
	Jessica Powell	Alto Neuroscience	51
	Brendan Merrell	OPTIMIZERx Corp	41
	Stephen Silvestro	OPTIMIZERx Corp	48
	William Moschella	Definitive Healthcare Corp	48
	Oliver Dolan	Frequency Therapeutics	43
	Christophe Louvion	National Research Corp	52
	Jeannine Lombardi	Definitive Healthcare Corp	N/A
	Julien Rongere	AC Immune	48

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California. Simulations Plus is traded on NASDAQ Exchange in the United States. Simulations Plus (SLP) is listed on NASDAQ Exchange in USA. Simulations Plus operates in the Health Care Technology space.

Management Performance

	Return On Equity	-0.41
	Return On Asset	0.0279

Simulations Plus Leadership Team

Elected by the shareholders, the Simulations Plus' board of directors comprises two types of representatives: Simulations Plus inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Simulations. The board's role is to monitor Simulations Plus' management team and ensure that shareholders' interests are well served. Simulations Plus' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Simulations Plus' outside directors are responsible for providing unbiased perspectives on the board's policies.

	Erik Guffrey, CoChief Officer
	MS MAS, CoFounder Chairman
	MS MS, Pres Division
	Marvin Waldman, Senior Fellow
	Viera Lukacova, Chief Officer
	Daniel Szot, Chief Officer
	Steven Chang, President Pharmacology
	Murry Alper, Global Communications
	Michael Lawless, Senior Scientist
	Josh Fohey, Senior Operations
	Christina Hendrickson, Director Marketing
	Jonathan Chauvin, President Solutions
	Bud JD, VP Officer
	Renie Dornbusch, Chief Communications
	Sandra Sharp, Global Strategies
	John MS, Cheminformatics PBPK
	Arlene Padron, Corporate Marketing
	William Frederick, Executive CFO
	Jill MS, President Solutions
	Jenna Rouse, Global Operations
	Brad Stefanovic, Head Insights
	Brett Howell, President Solutions
	Jennifer Presnell, Accounting Manager
	Grant Fowler, Senior Insights
	Daniel CPA, Vice Finance
	Shawn OConnor, Chief Officer
	Scott Siler, Chief Pharmacology
	Tanya Marvin, Marketing Manager
	Lindsay Luke, Executive Resources

Simulations Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Simulations Plus a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

	Return On Equity	-0.41
	Return On Asset	0.0279
	Profit Margin	-0.82 %
	Operating Margin	0.04 %
	Current Valuation	199.88 M
	Shares Outstanding	20.15 M
	Shares Owned By Insiders	17.31 %
	Shares Owned By Institutions	85.17 %
	Number Of Shares Shorted	1.33 M
	Price To Earning	75.17 X

Pair Trading with Simulations Plus

Using Simulations Plus in a pair-trading setup can improve risk control because gains and losses are judged against a second position instead of against the market alone. The key question is whether the second leg adds real hedge value instead of just creating a more complex version of the same risk.

Moving together with Simulations Stock

0.83	GLH	Global Health	Pair Corr
0.92	DH	DeFinitive Healthcare	Pair Corr
0.93	VEEV	Veeva Systems Class	Pair Corr
0.84	VSEE	VSee Health	Pair Corr

Moving against Simulations Stock

0.91	SVMRF	Magnora ASA	Pair Corr
0.9	NHC	National HealthCare	Pair Corr
0.83	LLYVK	Liberty Live Holdings	Pair Corr
0.75	RCIAF	Rogers Communications	Pair Corr
0.7	PUTRF	PTT Public	Pair Corr

Correlation-based analysis of Simulations Plus positions provides the foundation for tax-loss harvesting. The goal is to redeploy proceeds into a highly correlated asset that maintains Simulations Plus's risk contribution. Rolling correlation data for Simulations Plus helps assess whether candidate substitutes are stable or episodic. The correlation data below supports identifying viable temporary replacements for Simulations Plus.

For portfolio construction, the correlation of Simulations Plus with potential additions determines risk reduction value. Correlations that spike toward +1 during stress suggest Simulations Plus's diversification may disappear when most needed. High-frequency correlation analysis for Simulations Plus captures short-term co-movements from intraday data. Effective use of correlation data improves both diversification and risk-adjusted returns for Simulations Plus investors.

Pair trading evaluation alongside Correlation analysis adds hedging context for Simulations Plus. Values are based on observed price behavior across time frames.

Pair Correlation Correlation Matching

Additional Tools for Simulations Stock Analysis

	Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators
	Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
	Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated
	CEOs Directory Screen CEOs from public companies around the world
	Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
	USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA
	Equity Valuation Check real value of public entities based on technical and fundamental data
	Analyst Advice Analyst recommendations and target price estimates broken down by several categories
	Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance

Macroaxis provides analytical tools and reference data for investors of all levels to evaluate holdings and assess risk across market volatility, economic shifts, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC